Capital A Wealth Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Capital A Wealth Management’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24	Closed	-$18	–	923
2024 Q4	$18	Buy	+24	New	+$24	﹤0.01%	845

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Capital A Wealth Management's OMGA Position: Q1 2025 in Review

Capital A Wealth Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 24 shares — an estimated $18 sold.

Capital A Wealth Management first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $18 in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Capital A Wealth Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Capital A Wealth Management sold 24 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $18.
Capital A Wealth Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Capital A Wealth Management's Omega Therapeutics, Inc. Common Stock position peaked at $18 in Q4 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Capital A Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.